Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jul;81(1):e95-e97.
doi: 10.1016/j.jinf.2020.04.008. Epub 2020 Apr 17.

Risk factors associated with disease severity and length of hospital stay in COVID-19 patients

Affiliations
Comment

Risk factors associated with disease severity and length of hospital stay in COVID-19 patients

Xiaofan Liu et al. J Infect. 2020 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration Competing of Interest None.

Figures

Fig 1
Fig. 1
Risk factors associated with disease severity in COVID-19 patients. Univariate (a) and multivariate (b) logistic regression analysis in COVID-19 patients. OR (odds ratio), 95% CI (confidence interval) and p values are shown. Numbers in red are the number of patients considered for each variable.
Fig 2
Fig. 2
Risk factors associated with length of hospital stay in COVID-19 patients. (a) Graph showing length of hospital stay (days) in pneumonia or severe pneumonia patients. Data are median and IQR (interquartile range). P-value was calculated by Mann-Whitney U test. (b) Summary of demographic, laboratory and treatments analysed against length of hospital stay in COVID-19 patients. P-values were calculated by log-rank test or Spearman's Rank-Order correlation, as appropriate. (c) Kaplan-Meier plot showing the overall hospital stay in COVID-19 patients with normal or low lymphocyte count (< 1.1 × 109/L). Numbers below are n (%). P-value was calculated by log-rank test. (d) Kaplan-Meier plot showing the overall hospital stay in COVID-19 patients treated with or without glucocorticoids. Numbers below are n (%). P-value was calculated by log-rank test.

Comment in

Comment on

References

    1. Zhang Z., Yao W., Wang Y., Long C., Fu X. Wuhan and hubei COVID-19 mortality analysis reveals the critical role of timely supply of medical resources. J Infect. 2020 PubMed PMID: 32209384. - PMC - PubMed
    1. Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 PubMed PMID: 32192578. - PMC - PubMed
    1. Qin C., Zhou L., Hu Z., Zhang S., Yang S., Tao Y. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis Off Publ Infect Dis Soc Am. 2020 PubMed PMID: 32161940. - PMC - PubMed
    1. Furuhashi M., Moniwa N., Mita T., Fuseya T., Ishimura S., Ohno K. Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by Olmesartan, an angiotensin ii receptor blocker. Am J Hypertens. 2015;28(1):15–21. PubMed PMID: 24842388. - PubMed
    1. Ferrario C.M., Jessup J., Chappell M.C., Averill D.B., Brosnihan K.B., Tallant E.A. Effect of angiotensin-converting enzyme inhibition and angiotensin ii receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005;111(20):2605–2610. PubMed PMID: 15897343. - PubMed